followers 9 popularity
following 0
danielweb14982 is not in any groups


Customer Service
Daniel Web | danielweb14982

Global Cancer Tumor Profiling Market Forecasted to Gain Steady Growth at a CAGR of 18.20% through 2025

Jan 23rd 2019 at 1:01 AM

Looking at the current trends across the Cancer Tumor Profiling market, a new study has been included to the wide database of Market Research Hub (MRH). The assessment is titled "Global Cancer Tumor Profiling Market Size, Status and Forecast 2019-2025", which discourses the various market impacting factors like drivers, restraints and opportunities. Moreover, readers are informed about the competitive landscape which enlightens about the different players operating in the Cancer Tumor Profiling market together with their market value.

Request for free Sample @

Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid over-treatment of the cancer patients.

The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
In 2018, the global Cancer Tumor Profiling market size was 30200 million US$ and it is expected to reach 115600 million US$ by the end of 2025, with a CAGR of 18.2% during 2019-2025.

This report focuses on the global Cancer Tumor Profiling status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Tumor Profiling development in United States, Europe and China.

The key players covered in this study
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
Contextual Genomics

Market segment by Type, the product can be split into
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)

Market segment by Application, split into
Personalized Medicine
Biomarker Discovery
Research Applications

Market segment by Regions/Countries, this report covers
United States
Southeast Asia
Central & South America

The study objectives of this report are:
To analyze global Cancer Tumor Profiling status, future forecast, growth opportunity, key market and key players.
To present the Cancer Tumor Profiling development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Tumor Profiling are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Browse Full Report with TOC@

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type (2014-2025)
1.4.2 Next-generation Sequencing (NGS)
1.4.3 Polymerase Chain Reaction (PCR)
1.4.4 Immunohistochemistry (IHC)
1.4.5 In Situ Hybridization (ISH)
1.4.6 Microarray
1.4.7 Others
1.5 Market by Application
1.5.1 Global Cancer Tumor Profiling Market Share by Application (2014-2025)
1.5.2 Personalized Medicine
1.5.3 Diagnostics
1.5.4 Biomarker Discovery
1.5.5 Prognostics
1.5.6 Research Applications
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Tumor Profiling Market Size
2.2 Cancer Tumor Profiling Growth Trends by Regions
2.2.1 Cancer Tumor Profiling Market Size by Regions (2014-2025)
2.2.2 Cancer Tumor Profiling Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Tumor Profiling Market Size by Manufacturers
3.1.1 Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2018)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Tumor Profiling Key Players Head office and Area Served
3.3 Key Players Cancer Tumor Profiling Product/Solution/Service
3.4 Date of Enter into Cancer Tumor Profiling Market
3.5 Mergers & Acquisitions, Expansion Plans


Enquire about this Report -

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of health market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -

Please to comment

sign in

Remember Me

New to IM faceplate? join free!

Lost Password? click here